Jeffrey L. Ives

1.0k citations

24 papers · 775 indexed · h-index 12

Organic Chemistry top 5%
Molecular Biology
Pharmacology top 10%
Cellular and Molecular Neuroscience top 10%
Computational Theory and Mathematics top 5%

Co-authors: Harry H. Wasserman James Heym Dane Liston Douglas S. Chapin J.A. Nielsen Lorraine A. Lebel Kevin Ryan John E. Macor
Topics: Cholinesterase and Neurodegenerative Diseases (7 papers)Synthesis and Biological Evaluation (5 papers)Synthesis and Reactions of Organic Compounds (4 papers)
Cited by: Organic Chemistry Pharmacology Cellular and Molecular Neuroscience
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry The Journal of Organic Chemistry
Partner nations: United States China

In The Last Decade

Jeffrey L. Ives

23 papers receiving 736 citations

Peers

Countries citing papers authored by Jeffrey L. Ives

Since Specialization

Citations

This map shows the geographic impact of Jeffrey L. Ives's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey L. Ives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey L. Ives more than expected).

Fields of papers citing papers by Jeffrey L. Ives

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey L. Ives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey L. Ives. The network helps show where Jeffrey L. Ives may publish in the future.

Co-authorship network of co-authors of Jeffrey L. Ives

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey L. Ives. A scholar is included among the top collaborators of Jeffrey L. Ives based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey L. Ives. Jeffrey L. Ives is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Minimization of drug–drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators 2015 ·Bioorganic & Medicinal Chemistry Letters ·Jed L. Hubbs,Nathan O. Fuller,(unknown),Ruichao Shen,Jianguo Ma,Zhen Gong,Jian Jian Li,Timothy D. McKee,Robyn Loureiro,Barbara Tate,Jo Ann Dumin,Jeffrey L. Ives,Brian S. Bronk	6
2	Multikilogram-Scale Production of Cycloartenol Triterpenoid Glycosides as Synthetic Intermediates for a γ-Secretase Modulator 2014 ·Organic Process Research & Development ·Ruichao Shen,Nathan O. Fuller,(unknown),(unknown),Jed L. Hubbs,D. Haag,János Kovács,Steffen P. Creaser,Mark A. Findeis,Jeffrey L. Ives,Brian S. Bronk	3
3	Optimization of a Kilogram-Scale Synthesis of a Potent Cycloartenol Triterpenoid-Derived γ-Secretase Modulator 2014 ·Organic Process Research & Development ·Nathan O. Fuller,Jed L. Hubbs,(unknown),Ruichao Shen,Jeffrey L. Ives,(unknown),Brian S. Bronk	4
4	SAR investigations on a novel class of gamma-secretase modulators based on a unique scaffold 2013 ·MedChemComm ·(unknown),Jed L. Hubbs,Nathan O. Fuller,Steffen P. Creaser,Timothy D. McKee,Robyn Loureiro,Mark A. Findeis,Barbara Tate,Jeffrey L. Ives,Brian S. Bronk	8
5	Optimization of a Natural Product-Based Class of γ-Secretase Modulators 2012 ·Journal of Medicinal Chemistry ·Jed L. Hubbs,Nathan O. Fuller,(unknown),Ruichao Shen,Steffen P. Creaser,Timothy D. McKee,Robyn Loureiro,Barbara Tate,Weiming Xia,Jeffrey L. Ives,Brian S. Bronk	38
6	Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside 2012 ·ACS Medicinal Chemistry Letters ·Nathan O. Fuller,Jed L. Hubbs,(unknown),Steffen P. Creaser,Timothy D. McKee,Robyn Loureiro,Barbara Tate,Weiming Xia,Jeffrey L. Ives,Mark A. Findeis,Brian S. Bronk	18
7	5,7-Dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one: A Potent and Centrally-Selective Inhibitor of Acetylcholinesterase 1995 ·Journal of Medicinal Chemistry ·(unknown),Todd W. Butler,Douglas S. Chapin,(unknown),(unknown),Jeffrey L. Ives,Susan B. Jones,Dane Liston,A. Nagel	36
8	ChemInform Abstract: 5,7‐Dihydro‐3‐(2‐(1‐(phenylmethyl)‐4‐piperidinyl)ethyl)‐6H‐pyrrolo(3,2‐ f)‐1,2‐benzisoxazol‐6‐one: A Potent and Centrally‐Selective Inhibitor of Acetylcholinesterase with an Improved Margin of Safety. 1995 ·ChemInform ·(unknown),Todd W. Butler,Douglas S. Chapin,(unknown),(unknown),Jeffrey L. Ives,Shawn B. Jones,Dane Liston,A. Nagel,Deane M. Nason,J.A. Nielsen,Antonio Ramı́rez,Ismail A. Shalaby,William F. White	3
9	Design and Synthesis of 1-Heteroaryl-3-(1-benzyl-4-piperidinyl)propan-1-one Derivatives as Potent, Selective Acetylcholinesterase Inhibitors 1995 ·Journal of Medicinal Chemistry ·A. Nagel,Dane Liston,(unknown),(unknown),Lawrence A. Vincent,Douglas S. Chapin,Yuhpyng L. Chen,(unknown),Jeffrey L. Ives	38
10	Novel Benzisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase 1994 ·Journal of Medicinal Chemistry ·Anabella Villalobos,James F. Blake,Christopher K. Bíggers,Todd W. Butler,Douglas S. Chapin,Yuhpyng L. Chen,Jeffrey L. Ives,Shawn B. Jones,Dane Liston	92
11	ChemInform Abstract: Syntheses and Anticholinesterase Activity of Tetrahydrobenzazepine Carbamates. 1994 ·ChemInform ·(unknown),Dane Liston,J.A. Nielsen,Douglas S. Chapin,A. DUNAISKIS,(unknown),Jeffrey L. Ives,(unknown),Shawn B. Jones	1
12	ChemInform Abstract: Syntheses, Resolution, and Structure—Activity Relationships of Potent Acetylcholinesterase Inhibitors: 8‐Carbaphysostigmine Analogues. 1993 ·ChemInform ·(unknown),J.A. Nielsen,(unknown),A. DUNAISKIS,Shawn B. Jones,(unknown),Jillian G. Johnson,Jeffrey L. Ives,Dane Liston	1
13	ChemInform Abstract: Thiazole as a Carbonyl Bioisostere. A Novel Class of Highly Potent and Selective 5‐HT3 Receptor Antagonists. 1991 ·ChemInform ·Terry Rosen,A. Nagel,(unknown),Jeffrey L. Ives,(unknown),Alan H. Ganong,(unknown),James Heym,Stafford McLean,(unknown),Anne W. Schmidt,Thomas Seeger,Chester J. Siok,Lawrence A. Vincent	1
14	ChemInform Abstract: Calcium‐Independent Phosphodiesterase Inhibitors as Putative Antidepressants: (3‐(Bicycloalkoxy)‐4‐methoxyphenyl)‐2‐ imidazolidinones. 1991 ·ChemInform ·Nicholas A. Saccomano,Fredric J. Vinick,B. Kenneth Koe,J.A. Nielsen,(unknown),(unknown),(unknown),(unknown),(unknown),Douglas S. Chapin,Lorraine A. Lebel,(unknown),(unknown),Jonathan L. Johnson,Jeffrey L. Ives,Ian H. Williams	5
15	3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1) agonist and rotationally restricted phenolic analog of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole 1990 ·Journal of Medicinal Chemistry* ·John E. Macor,Catherine A. Burkhart,James Heym,Jeffrey L. Ives,Lorraine A. Lebel,Michael E. Newman,J.A. Nielsen,Kevin Ryan,David W. Schulz	138
16	Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonists 1990 ·Journal of Medicinal Chemistry ·Terry Rosen,A. Nagel,(unknown),Jeffrey L. Ives,(unknown),Alan H. Ganong,(unknown),James Heym,Stafford McLean	29
17	Synthesis, in vitro binding profile, and CNS penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole 1990 ·Journal of Medicinal Chemistry ·Terry Rosen,Thomas Seeger,Stafford McLean,A. Nagel,Jeffrey L. Ives,(unknown),David L. Bryce,J. M. Furman,(unknown)	5
18	The Reductive Decyanation of Nitriles by Alkali Fusion 1980 ·Synthetic Communications ·Charles E. Berkoff,(unknown),David Kirkpatrick,Jeffrey L. Ives	8
19	Reaction of singlet oxygen with enamino lactones. Conversion of lactones to .alpha.-keto lactones 1978 ·The Journal of Organic Chemistry ·Harry H. Wasserman,Jeffrey L. Ives	30
20	A novel method for converting ketones to .alpha.-diketones. The reaction of enamino ketones with singlet oxygen 1976 ·Journal of the American Chemical Society ·(unknown),Jeffrey L. Ives	46

About Jeffrey L. Ives

Jeffrey L. Ives is a scholar working on Organic Chemistry, Pharmacology and Catalysis, having authored 24 papers that have together received 775 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (7 papers), Synthesis and Biological Evaluation (5 papers) and Synthesis and Reactions of Organic Compounds (4 papers). The work is most often cited by research in Organic Chemistry (426 citations), Pharmacology (164 citations) and Cellular and Molecular Neuroscience (144 citations). Jeffrey L. Ives has collaborated with scholars based in United States and China. Frequent co-authors include Harry H. Wasserman, James Heym, Dane Liston, Douglas S. Chapin, J.A. Nielsen, Lorraine A. Lebel, Kevin Ryan, John E. Macor, David W. Schulz and Michael E. Newman. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact